NEUBERG EXPANDS LEADERSHIP TEAM
Ropes in Finance & Accounting veteran VB Gopal Krishnan as Group CFO Neuberg Diagnostics Private Limited, a StartUp in the PathLab chain segment, today announced the appointment of Mr. VB Gopal Krishnan as the Group Chief
Ropes in Finance & Accounting veteran VB Gopal Krishnan as Group CFO
Neuberg Diagnostics Private Limited, a StartUp in the PathLab chain segment, today announced the appointment of Mr. VB Gopal Krishnan as the Group Chief Financial Officer.
Mr. Gopal Krishnan, who has over two decades of experience in the areas of Treasury, Project Finance, System Implementation, Corporate Affairs and Accounting, Debt restructuring, Business Finance, Costing and Taxation will be heading Neuberg’s Financial, legal and IT functions.
“We are delighted to have Gopal onboard at Neuberg. He is a seasoned professional with a proven track record in improving operations, effecting business growth and maximizing profits through innovative financial strategies. In his new role, he will be at the helm of Neuberg’s finances, organizational growth, and expansion plans. I am confident that he will bring in a lot of experience and value to Neuberg and our leadership team. We look forward to an exciting journey with him and wish him all the success at Neuberg,” says Dr. GSK Velu, Chairman & Managing Director, Neuberg Diagnostics Private Limited.
Mr. Gopal Krishnan is a Commerce Graduate, an Associate Member of Institute of Chartered Accountants of India and Diploma in International Financial Reporting set and Accredited by Association of Chartered Certified Accountants UK. Prior to joining Neuberg, he served as the CFO at Rajshree Sugars and Chemicals Limited. In his earlier assignments he held responsible positions at Uttam Sucrotech international Limited, EID Parry (India) Limited and Paharpur Cooling Towers Limited.
Commenting on his appointment, Mr. Gopal Krishnan said, “Neuberg has tremendous potential in the diagnostics space today. I am honored and overwhelmed to be part of this dynamic organization promoted by none other than Dr. GSK Velu, a name that needs no introduction in the healthcare industry. I look forward to closely working with the entire team in realizing Neuberg Diagnostics’ vision and mission. My primary focus will be to grow Neuberg to a strong position in the country and to model the desired changes for further growth and expansion.”